Cystic fibrosis. Cystic fibrosis
Conditions
Interventions
Intervention group: After receiving informed consent from the parents of patients and children over 6 years of age, all standard and required drugs for cystic fibrosis patients are prescribed and in a
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to No maximum
Inclusion criteria
Inclusion criteria: All cystic fibrosis patients over 6 years of age should be referred to the pulmonary clinic of Mofid Children's Hospital, diagnosed by a pediatric lung specialist. Conscious consent of parents of children and children over 6 years of age
Exclusion criteria
Exclusion criteria: Cystic fibrosis patients under 6 years of age referred to the pulmonary clinic of Mofid Children's Hospital Patients in need of hospitalization Patients who have attack symptoms of the disease (increased cough, sputum, fever, and need for hospitalization). Patients with underlying diseases such as allergic bronchopulmonary aspergillosis, heart failure and tuberculosis. Patients with other acute illnesses during treatment. Patients who are allergic to any of the components of the compound honey syrup. Patients who have decided to leave the study at their own request. Patients who are unable to co-operate with the FeNO test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fractional exhalation Nitric Oxide. Timepoint: At the beginning of the study (before the start of the intervention) and the twelfth week after the start of the compound honey syrup. Method of measurement: FeNO monitor (NObreath®). | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: At the beginning of the study (before the start of the intervention) and the twelfth week after the start of the compound honey syrup. Method of measurement: Scales.;Height. Timepoint: At the beginning of the study (before the start of the intervention) and the twelfth week after the start of the compound honey syrup. Method of measurement: Standing position and by meters.;Body Mass Index (BMI). Timepoint: At the beginning of the study (before the start of the intervention) and the twelfth week after the start of the compound honey syrup. Method of measurement: Weight/(height)2.;Staphylococcus aureus bacterial culture. Timepoint: At the beginning of the study (before the start of the intervention) and the twelfth week after the start of the compound honey syrup. Method of measurement: Preparation of sputum or throat swab after chest physiotherapy in the absence of sputum.;Pseudomonas aeruginosa bacterial culture. Timepoint: At the beginning of the study (before the start of the intervention) and the twelfth week after the start of the compound honey syrup. Method of measurement: Preparation of sputum or throat swab after chest physiotherapy in the absence of sputum. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Tahermohammadi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed